Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Raghav Joshi, Edi Goihberg, Wenying Ren, Monika Pilichowska & Paul Mathew. (2017) Proteolytic fragments of fibronectin function as matrikines driving the chemotactic affinity of prostate cancer cells to human bone marrow mesenchymal stromal cells via the α5β1 integrin. Cell Adhesion & Migration 11:4, pages 305-315.
Read now
Read now
Monika Ehnman & Arne Östman. (2014) Therapeutic targeting of platelet-derived growth factor receptors in solid tumors. Expert Opinion on Investigational Drugs 23:2, pages 211-226.
Read now
Read now
Pavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos & Michael Koutsilieris. (2013) Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer. Expert Opinion on Investigational Drugs 22:11, pages 1385-1400.
Read now
Read now
Tomi K Sawyer, Joe C Wu, Jonathon R Sawyer & Jessie M English. (2013) Protein kinase inhibitors: breakthrough medicines and the next generation. Expert Opinion on Investigational Drugs 22:6, pages 675-678.
Read now
Read now
Articles from other publishers (24)
Santanu Maji, Anjan K. Pradhan, Amit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, Chunqing Guo, Jolene J. Windle, Mark A. Subler, Xiang-Yang Wang, Oliver J. Semmes, Julius O. Nyalwidhe, Nitai Mukhopadhyay, Asit Kr. Paul, Bryce Hatfield, Michael M. Levit, Esha Madan, Devanand Sarkar, Luni Emdad, David J. Cohen, Rajan Gogna, Webster K. Cavenee, Swadesh K. Das & Paul B. Fisher. (2023) MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Proceedings of the National Academy of Sciences 120:45.
Crossref
Crossref
Melissa A. Marchal, Devon L. Moose, Afshin Varzavand, Nicole E. Jordan, Destiney Taylor, Munir R. Tanas, James A. Brown, Michael D. Henry & Christopher S. Stipp. (2023) Abl kinases can function as suppressors of tumor progression and metastasis. Frontiers in Oncology 13.
Crossref
Crossref
Jongsu Kim, Kyung Won Hwang, Hye Jung Lee & Hong Sook Kim. (2022) Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer. Journal of Personalized Medicine 12:11, pages 1818.
Crossref
Crossref
Omar Fahmy, Nabil A. Alhakamy, Waleed Y. Rizg, Alaa Bagalagel, Abdulmohsin J. Alamoudi, Hibah M. Aldawsari, Aiah M. Khateb, Basmah M. Eldakhakhny, Usama A. Fahmy, Wesam H. Abdulaal, Claudia G. Fresta & Giuseppe Caruso. (2021) Updates on Molecular and Biochemical Development and Progression of Prostate Cancer. Journal of Clinical Medicine 10:21, pages 5127.
Crossref
Crossref
Shiqi Li, Fuhui Zhang, Xiuchan Xiao, Yanzhi Guo, Zhining Wen, Menglong Li & Xuemei Pu. (2021) Prediction of Synergistic Drug Combinations for Prostate Cancer by Transcriptomic and Network Characteristics. Frontiers in Pharmacology 12.
Crossref
Crossref
Anantha N. Nagappa, Shvetank Bhatt & Jovita Kanoujia. (2020) Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors. Current Enzyme Inhibition 16:1, pages 90-105.
Crossref
Crossref
Elena Laura Mazzoldi, Simona Pavan, Giorgia Pilotto, Kevin Leone, Anna Pagotto, Simona Frezzini, Maria Ornella Nicoletto, Alberto Amadori & Anna Pastò. (2019) A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer. Cell Death & Disease 10:6.
Crossref
Crossref
Takeshi Sasaki, Omar E. Franco, Kohshi Ohishi, Yana Filipovich, Kenichiro Ishii, Susan E. Crawford, Naoto Takahashi, Naoyuki Katayama, Yoshiki Sugimura & Simon W. Hayward. (2018) Tyrosine kinase inhibitor therapy prescribed for non‐urologic diseases can modify PSA titers in urology patients. The Prostate 79:3, pages 259-264.
Crossref
Crossref
Oliver W. Hakenberg, Jose Luis Perez-Gracia, Daniel Castellano, Tomasz Demkow, Tarek Ali, Orazio Caffo, Axel Heidenreich, Wolfgang Schultze-Seemann, Brieuc Sautois, Ivan Pavlik, Amy Qin, Ruslan D. Novosiadly, Ashwin Shahir, Robert IlariaJr.Jr. & Johannes Nippgen. (2019) Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. European Journal of Cancer 107, pages 186-195.
Crossref
Crossref
Natalia Papadopoulos & Johan Lennartsson. (2018) The PDGF/PDGFR pathway as a drug target. Molecular Aspects of Medicine 62, pages 75-88.
Crossref
Crossref
Alexandra Bukchin, Nataliya Kuplennik, Ángel M. Carcaboso & Alejandro Sosnik. (2018) Effect of growing glycosylation extents on the self-assembly and active targeting in vitro of branched poly(ethylene oxide)-poly(propylene oxide) block copolymers. Applied Materials Today 11, pages 57-69.
Crossref
Crossref
Robert RoskoskiJr.Jr.. (2018) The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders. Pharmacological Research 129, pages 65-83.
Crossref
Crossref
M. Yu. Shkurnikov & B. Ya. Alekseev. (2018) Expression of platelet-derived growth factor alpha and beta genes PDGFRA and PDGFRB associated with biochemical recurrence of prostate cancer after radical prostatectomy. Cancer Urology 13:4, pages 45-50.
Crossref
Crossref
C.‐H. Heldin, J. Lennartsson & B. Westermark. (2017) Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis. Journal of Internal Medicine 283:1, pages 16-44.
Crossref
Crossref
Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Donnem, Hiten R. H. Patel, Lill-Tove Busund, Roy M. Bremnes & Sigve Andersen. (2017) High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Scientific Reports 7:1.
Crossref
Crossref
Elena Jachetti, Alice Rigoni, Lucia Bongiovanni, Ivano Arioli, Laura Botti, Mariella Parenza, Valeria Cancila, Claudia Chiodoni, Fabrizio Festinese, Matteo Bellone, Regina Tardanico, Claudio Tripodo & Mario P. Colombo. (2017) Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β. Molecular Cancer Therapeutics 16:2, pages 365-375.
Crossref
Crossref
Mohammed A. Kassem, Hossam S. El-Sawy, Fathy I. Abd-Allah, Tamer M. Abdelghany & Khalid M. El-Say. (2017) Maximizing the Therapeutic Efficacy of Imatinib Mesylate–Loaded Niosomes on Human Colon Adenocarcinoma Using Box-Behnken Design. Journal of Pharmaceutical Sciences 106:1, pages 111-122.
Crossref
Crossref
Giuseppe Tridente. 2017. Adverse Events and Oncotargeted Kinase Inhibitors. Adverse Events and Oncotargeted Kinase Inhibitors
97
122
.
Afshin Varzavand, Will Hacker, Deqin Ma, Katherine Gibson-Corley, Maria Hawayek, Omar J. Tayh, James A. Brown, Michael D. Henry & Christopher S. Stipp. (2016) α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway. Cancer Research 76:22, pages 6577-6587.
Crossref
Crossref
Seyed Ataollah Sadat Shandiz, Marjan Khosravani, Sepideh Mohammadi, Hassan Noorbazargan, Amir Mirzaie, Davoud Nouri Inanlou, Mojgan Dalirsaber Jalali, Hamidreza Jouzaghkar, Fahimeh Baghbani-Arani & Behta Keshavarz-Pakseresht. (2016) Evaluation of imatinib mesylate (Gleevec) on KAI1/CD82 gene expression in breast cancer MCF-7 cells using quantitative real-time PCR. Asian Pacific Journal of Tropical Biomedicine 6:2, pages 159-163.
Crossref
Crossref
Seyed Ataollah Sadat Shandiz, Soheila Farasati, Banafshe Saeedi, Fahimeh Baghbani-Arani, Elham Akbari Asl, Behta Keshavarz-Pakseresht, Arian Rahimi, Artin Assadi, Hassan Noorbazargan, Maryam Rahimpour Hesari & Amir Mirzaie. (2016) Up regulation of KAI1 gene expression and apoptosis effect of imatinib mesylate in gastric adenocarcinoma (AGS) cell line. Asian Pacific Journal of Tropical Disease 6:2, pages 120-125.
Crossref
Crossref
Gaurav Joshi, Pankaj Kumar Singh, Arvind Negi, Anil Rana, Sandeep Singh & Raj Kumar. (2015) Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents. Chemico-Biological Interactions 240, pages 120-133.
Crossref
Crossref
Anna C. Jones, Kresta S. Antillon, Shannon M. Jenkins, Sara N. Janos, Heidi N. Overton, Dor S. Shoshan, Edgar G. Fischer, Kristina A. Trujillo & Marco Bisoffi. (2015) Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumor Adjacent Tissue. PLOS ONE 10:3, pages e0119314.
Crossref
Crossref
Henrique J. Cardoso, Marília I. Figueira, Sara Correia, Cátia V. Vaz & Sílvia Socorro. (2014) The SCF/c-KIT system in the male: Survival strategies in fertility and cancer. Molecular Reproduction and Development 81:12, pages 1064-1079.
Crossref
Crossref